GLP-1 Receptor Agonists Versus Bariatric Surgery: Effects of Weight Loss and BMI on Subsequent General Surgical Procedures - PubMed
2 days ago
- #bariatric-surgery
- #obesity
- #GLP-1-agonists
- Obesity and T2DM increase postoperative risks, including higher surgical site infections and complications.
- Study compares weight loss interventions: metabolic bariatric surgery (MBS) and GLP-1 receptor agonists (GLP-1RA).
- MBS leads to greater BMI reduction than GLP-1RA (-9.89 mean difference).
- Higher BMI at surgery correlates with increased complications and longer hospital stays.
- MBS associated with lower complication odds (OR: 0.87).
- Supports preoperative weight loss to mitigate surgical risks.